Discover
LNSR
LENSAR, Inc.
5.84
2 x 4.15
2 x 7.32
bid
ask
+
0.13
2.28%
2 @ 04:00 PM
5.84 +0.00 (0.00%)
| Ytd | -49.79% | |
| 1y | -54.34% |
5.66
day range
5.84
5.06
52 week range
13.47
| Open | 5.72 | Prev Close | 5.71 | Low | 5.66 | High | 5.84 | Mkt Cap | 71.72M |
| Vol | 86.39K | Avg Vol | 84.47K | EPS | -0.55 | P/E | N/A | Forward P/E | -12.18 |
| Beta | 0.58 | Short Ratio | 1.20 | Inst. Own | 42.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 5.69 | 200-d Avg | 9.51 | 1yr Est | 11.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-07 | 2024-09 | 0 | -0.13 | N/A | N/A |
| 2024-08-08 | 2024-06 | 0 | -0.53 | N/A | N/A |
| 2024-05-09 | 2024-03 | 0 | -0.19 | N/A | N/A |
| 2024-03-04 | 2023-12 | 0 | -0.35 | N/A | N/A |
| 2023-11-09 | 2023-09 | 0 | -0.23 | N/A | N/A |
| 2023-08-09 | 2023-06 | 0 | -0.81 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-03-19 | Lake Street | Upgrade | Buy | |
| 2021-11-22 | BTIG | Upgrade | Buy | |
| 2021-02-24 | SVB Leerink | Upgrade | Outperform |
Profile
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-05-05 | CONNAUGHTON ALAN B. | Chief Operating Officer | 324.49K | Stock Award(Grant) |
| 2024-05-05 | CURTIS NICHOLAS T | Chief Executive Officer | 864.44K | Stock Award(Grant) |
| 2024-05-06 | ELLIS THOMAS B. | Director and Beneficial Owner of more than 10% of a Class of Security | 1.13M | Stock Award(Grant) |
| 2024-05-06 | HAMMER TODD B. | Director and Beneficial Owner of more than 10% of a Class of Security | 1.13M | Stock Award(Grant) |
| 2024-05-06 | LINDSTROM RICHARD L | Director | 239.04K | Stock Award(Grant) |
| 2024-05-06 | LINK WILLIAM J | Director | 543.27K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Park West Asset Management LLC | 989.95K | 8.56M | 8.52% |
| 2024-09-29 | Dimensional Fund Advisors LP | 648.96K | 5.61M | 5.59% |
| 2024-09-29 | Brandes Investment Partners L.P. | 443.40K | 3.84M | 3.82% |
| 2024-09-29 | Vanguard Group Inc | 433.47K | 3.75M | 3.73% |
| 2024-09-29 | Renaissance Technologies, LLC | 307.95K | 2.66M | 2.65% |
| 2024-09-29 | DCF Advisers, LLC | 240.60K | 2.08M | 2.07% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 282.93K | 2.45M | 2.44% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 133.24K | 1.15M | 1.15% |
| 2024-07-30 | DFA U.S. Targeted Value Portfolio | 116.72K | 1.01M | 1.00% |
| 2024-07-30 | DFA U.S. Small Cap Series | 102.78K | 889.00K | 0.88% |
| 2024-07-30 | DFA U.S. Small Cap Value Series | 100.41K | 868.54K | 0.86% |
| 2024-09-29 | Brandes Small Cap Value Fund | 94.18K | 814.64K | 0.81% |